Form 4 for NKTR NEKTAR THERAPEUTICS
Accepted 2023-09-20 00:00:00 ET · period of report 2023-09-18 · accession 0001209191-23-050223 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-20 | 2023-09-18 | NKTR | Curet Myriam | Dir | S - Sale | $0.69 | -4,359 | 27.4K | -14% | -$3,008 |
| D | 2023-09-20 | 2023-09-19 | NKTR | Curet Myriam | Dir | A - Grant | $0.00 | +85.0K | 85.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-18 | S | D | 4,359 | $0.69 | 27,418 | D | — | — | (F1) Represents the number of shares required to be sold by the reporting person to cover tax obligations in connection with the vesting of certain RSUs held by the reporting person. This sale is mandated by the reporting person's previous election under the Issuer's equity incentive plans to require the satisfaction of tax obligations to be funded by a "sell to cover" transaction. |
| 2 | Derivative | Stock Option | 2023-09-19 | A | A | 85,000 | $0.00 | 85,000 | D | $0.68 · — to 2031-09-18 | 85,000 Common Stock | (F2) This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023. |